Why is Aarti Drugs falling/rising?

As of 19-Aug, Aarti Drugs Ltd's stock price is currently at Rs 490.30, reflecting a decrease of Rs 14.6 or 2.89%. The stock has underperformed its sector today by 2.76%, touching an intraday low of Rs 487.45. Despite a recent increase in investor participation, with delivery volume rising significantly, the stock has shown mixed performance over various periods, including a 6.24% decline over the past month and a 6.82% drop over the past year. However, the company maintains a high return on capital employed (ROCE) of 17.84% and a low debt-to-equity ratio of 0.45, indicating strong management efficiency and financial stability. The stock is currently trading at a discount compared to its peers, despite a 20.4% increase in profits over the past year, suggesting that the recent price decline may not reflect the underlying fundamentals.
In the broader market context, Aarti Drugs' short-term performance has lagged behind the benchmark Sensex, which has gained 1.76% over the past week, while Aarti Drugs has only increased by 0.47%. This underperformance may contribute to investor sentiment affecting the stock negatively. Additionally, while the stock has shown positive long-term returns over three years at 9.81%, the significant declines over one and five years highlight ongoing challenges. Overall, the combination of recent price declines, sector underperformance, and mixed historical returns may be influencing the stock's current downward movement.